Molecular mechanism of hypertension-induced renal injury: the role of HIF-1alpha
高血压肾损伤的分子机制:HIF-1α的作用
基本信息
- 批准号:9383995
- 负责人:
- 金额:$ 23.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-16 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcute Renal Failure with Renal Papillary NecrosisAngiotensin IIAnimal ModelAnimalsApplications GrantsAttenuatedBlood PressureCellsChronicChronic Kidney FailureCollagenDataDisease modelDoctor of PhilosophyEnzymesEsthesiaFibrosisGene Expression RegulationGenesHomeostasisHumanHypertensionHypoxia Inducible FactorImpairmentInfarctionInjuryKidneyLeadMechanicsMediatingMediator of activation proteinModelingMolecularMusOxygenPathogenicityPathway interactionsPatientsPerfusionPlasminogen InactivatorsPlayProcollagen-Proline DioxygenaseProteinsRattusRegulationRoleStressTechniquesTestingTissue Inhibitor of MetalloproteinasesTissuesUp-RegulationWorkcell typeconnective tissue growth factorglomerulosclerosishypertension treatmenthypoxia inducible factor 1interstitialkidney cellmechanical pressuremembernew therapeutic targetpodocytepressurereceptorrenal hypoxiasensorslit diaphragmsmall hairpin RNAtranscription factortransmission process
项目摘要
Hypoxia inducible factor (HIF)-1α is a transcription factor that has been shown to be up-regulated in almost all
types of chronic kidney diseases (CKD). HIF-1α stimulates the collagen accumulation by activating fibrogenic
factors. There is evidence suggesting that the long-term activation of HIF-1α is injurious in CKD, although
upregulation of HIF-1α is protective in acute kidney injury. The coexistent hypertension plays a predominant
role in the progression of CKD. Despite the findings that impaired renal autoregulation transmits the elevated
renal perfusion pressure (RPP) into the renal microvasculature, causing RPP-induced renal injury in CKD, little
is known regarding the molecular mechanism mediating RPP-induced injury. Our preliminary data showed that
silencing of HIF-1α attenuated renal injury without effect on hypertension in a rat 5/6 renal ablation/infarction
model (5/6 A/I); maintaining a normal RPP blocked the increase of renal HIF-1α and suppressed the renal
injury in this CKD model, indicating that HIF-1α may mediate RPP-induced renal injury. HIF prolyl-
hydroxylases (prolyl hydroxylase domain-containing proteins, PHDs) are the major enzymes to promote the
degradation of HIF-1α and present in the kidneys to regulate renal HIF-1α. We recently showed that PHDs play
a critical role in TGF-- and ANG II-induced activation of HIF-1α and consequent injuries in renal cells. Our
preliminary data showed that renal PHD activity was inhibited by elevated RPP and that activating PHD activity
attenuated renal injury in 5/6 A/I rats. Thus, PHD-mediated regulation of HIF-1α could be an important
mechanism mediating RPP-induced injury. Further, the PHD activity is inhibited by the activation of TRPC6, a
member of the Transient Receptor Potential Channels. The activation of TRPC6 is known to produce renal
injury. Moreover, TRPC6 participates in the mechanical/pressure sensation in various cell types, including
podocytes. Therefore, TRPC6 may be the upstream mediator that transmits the RPP stress into downstream
molecular pathways to cause RPP-induced injury. Our preliminary data showed that the levels of renal TRPC6
was increased, which was inhibited by servo-control to block the increase of RPP in rats with 5/6 A/I. In
addition, TRPC6 shRNA blocked the increase of HIF-1α in the kidneys of 5/6 A/I rats. The above information
leads to a hypothesis that the elevated RPP activates TRPC6, which inhibits PHD activity to induce HIF-1α-
mediated profibrogenic genes, consequently causing renal injuries in CKD. Three specific aims are proposed.
Aim 1: To test the hypothesis that over-activation of HIF-1α mediates RPP-induced chronic renal injury in CKD.
Aim 2: To test the hypothesis that elevated RPP inhibits PHD activity to up-regulate HIF-1α, thereby producing
chronic renal injury in CKD. Aim 3: To test the hypothesis that TRPC6 is the upstream regulator sensing
pressure stress to regulate PHD/HIF-1α pathway in RPP-induced renal injury in CKD. The results from these
proposed studies will define an important molecular mechanism associated with TRPC6/PHD/HIF-1α pathway
in RPP-induced injury in CKD, which will ultimately suggest new therapeutic targets for CKD.
缺氧诱导因子(Hypoxia inducible factor, HIF)-1α是一种在几乎所有疾病中均上调的转录因子
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ningjun Li其他文献
Ningjun Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ningjun Li', 18)}}的其他基金
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.
抑制脂肪酸酰胺水解酶作为预防顺铂肾毒性的新策略。
- 批准号:
10684803 - 财政年份:2022
- 资助金额:
$ 23.25万 - 项目类别:
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.
抑制脂肪酸酰胺水解酶作为预防顺铂肾毒性的新策略。
- 批准号:
10513011 - 财政年份:2022
- 资助金额:
$ 23.25万 - 项目类别:
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension
盐敏感性高血压中的肾 1-磷酸鞘氨醇受体 1
- 批准号:
10319594 - 财政年份:2019
- 资助金额:
$ 23.25万 - 项目类别:
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension
盐敏感性高血压中的肾 1-磷酸鞘氨醇受体 1
- 批准号:
10064007 - 财政年份:2019
- 资助金额:
$ 23.25万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8207205 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8386965 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8024001 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8584315 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure
肾髓质HIF脯氨酰羟化酶与血压盐敏感性
- 批准号:
7841255 - 财政年份:2009
- 资助金额:
$ 23.25万 - 项目类别:
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure
肾髓质HIF脯氨酰羟化酶与血压盐敏感性
- 批准号:
7481007 - 财政年份:2007
- 资助金额:
$ 23.25万 - 项目类别:














{{item.name}}会员




